IL232385A0 - שיטות לטיפול שיגדון בתת–אוכלוסיות של חולים - Google Patents

שיטות לטיפול שיגדון בתת–אוכלוסיות של חולים

Info

Publication number
IL232385A0
IL232385A0 IL232385A IL23238514A IL232385A0 IL 232385 A0 IL232385 A0 IL 232385A0 IL 232385 A IL232385 A IL 232385A IL 23238514 A IL23238514 A IL 23238514A IL 232385 A0 IL232385 A0 IL 232385A0
Authority
IL
Israel
Prior art keywords
trating
gout
methods
patient subpopulations
subpopulations
Prior art date
Application number
IL232385A
Other languages
English (en)
Other versions
IL232385A (he
Original Assignee
Metabolex Inc
Cymabay Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolex Inc, Cymabay Therapeutics Inc filed Critical Metabolex Inc
Publication of IL232385A0 publication Critical patent/IL232385A0/he
Publication of IL232385A publication Critical patent/IL232385A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL232385A 2011-11-04 2014-04-30 שימוש בתרכובות הלופנאט או חומצה הלפונית להכנת תרופות לטיפול בהיפראוריצימיה במטופלי במטופלים עם שגדון ,היפראוריצימיה או ליקוי בתפקוד הכליות IL232385A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/059425 WO2013066352A1 (en) 2011-11-04 2011-11-04 Methods for treating gout in patient subpopulations

Publications (2)

Publication Number Publication Date
IL232385A0 true IL232385A0 (he) 2014-06-30
IL232385A IL232385A (he) 2017-10-31

Family

ID=48192536

Family Applications (1)

Application Number Title Priority Date Filing Date
IL232385A IL232385A (he) 2011-11-04 2014-04-30 שימוש בתרכובות הלופנאט או חומצה הלפונית להכנת תרופות לטיפול בהיפראוריצימיה במטופלי במטופלים עם שגדון ,היפראוריצימיה או ליקוי בתפקוד הכליות

Country Status (14)

Country Link
EP (1) EP2775835A4 (he)
JP (1) JP6047172B2 (he)
KR (1) KR101848122B1 (he)
CN (1) CN104066323A (he)
AU (1) AU2011380509B2 (he)
BR (1) BR112014010693A2 (he)
CA (1) CA2859689C (he)
CL (1) CL2014001156A1 (he)
IL (1) IL232385A (he)
MX (1) MX354846B (he)
NZ (1) NZ624714A (he)
SG (1) SG11201402027PA (he)
WO (1) WO2013066352A1 (he)
ZA (1) ZA201403574B (he)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201406495UA (en) * 2012-04-13 2014-11-27 Cymabay Therapeutics Inc Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent
CN106036135A (zh) * 2014-07-25 2016-10-26 许伟琦 一种防止结石、快速排结石的药物、组合物、兽药
CN105920022A (zh) * 2016-05-12 2016-09-07 成都易创思生物科技有限公司 一种抗痛风药物复方制剂
US11446317B2 (en) * 2017-10-26 2022-09-20 Otsuka Pharmaceutical Co., Ltd. Inositol phosphate-containing composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250191A (en) * 1978-11-30 1981-02-10 Edwards K David Preventing renal failure
US6262118B1 (en) * 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
BRPI0819847B1 (pt) * 2007-11-27 2022-01-11 Ardea Biosciences, Inc Compostos e composições

Also Published As

Publication number Publication date
AU2011380509B2 (en) 2016-05-19
NZ624714A (en) 2016-01-29
KR101848122B1 (ko) 2018-04-11
CL2014001156A1 (es) 2015-01-16
BR112014010693A2 (pt) 2020-11-10
WO2013066352A1 (en) 2013-05-10
MX2014005399A (es) 2015-04-08
SG11201402027PA (en) 2014-09-26
MX354846B (es) 2018-03-22
CA2859689C (en) 2018-05-22
CA2859689A1 (en) 2013-05-10
EP2775835A1 (en) 2014-09-17
KR20140123927A (ko) 2014-10-23
EP2775835A4 (en) 2015-07-29
JP6047172B2 (ja) 2016-12-21
IL232385A (he) 2017-10-31
CN104066323A (zh) 2014-09-24
ZA201403574B (en) 2015-11-25
JP2014532759A (ja) 2014-12-08
AU2011380509A1 (en) 2014-05-29

Similar Documents

Publication Publication Date Title
EP2767033A4 (en) CONNECTING DEVICES
GB201108156D0 (en) Apparatus
PL2758218T3 (pl) Urządzenie wspomagające odrywanie
GB201114594D0 (en) Apparatus
GB201105779D0 (en) Apparatus
EP2682297A4 (en) VEHICLE ACTUATING APPARATUS
GB201120321D0 (en) Apparatus
TWI563551B (en) Holding device
PL2773241T3 (pl) Urządzenie przytrzymujące
PL2675666T3 (pl) Urządzenie do mycia kół
GB201210194D0 (en) Labelling method
GB201104046D0 (en) Apparatus
GB201120971D0 (en) Apparatus
GB201221250D0 (en) Information processing device
SG11201402129VA (en) Intra-vehicular information provision device
ZA201403574B (en) Methods for treating gout in patient subpopulations
GB201101219D0 (en) Method
GB2488026B (en) Moling apparatus
GB201117604D0 (en) Carrying apparatus
GB201121008D0 (en) Apparatus & method
GB201019076D0 (en) Screenwash recovery apparatus
GB201114106D0 (en) Combining apparatus
GB201111670D0 (en) Method & apparatus
GB201107317D0 (en) Apparatus
GB201103768D0 (en) Apparatus

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed